551 related articles for article (PubMed ID: 23007005)
21. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
[TBL] [Abstract][Full Text] [Related]
22. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients.
Miyoshi J; Matsuoka K; Inoue N; Hisamatsu T; Ichikawa R; Yajima T; Okamoto S; Naganuma M; Sato T; Kanai T; Ogata H; Iwao Y; Hibi T
J Crohns Colitis; 2013 Dec; 7(12):e609-14. PubMed ID: 23680174
[TBL] [Abstract][Full Text] [Related]
23. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
24. Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy.
López-Palacios N; Mendoza JL; Taxonera C; Lana R; López-Jamar JM; Díaz-Rubio M
Eur J Intern Med; 2011 Dec; 22(6):621-5. PubMed ID: 22075292
[TBL] [Abstract][Full Text] [Related]
25. Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.
Kim JH; Cheon JH; Park Y; Lee HJ; Park SJ; Kim TI; Kim WH
Scand J Gastroenterol; 2016 Sep; 51(9):1069-74. PubMed ID: 26895215
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.
Ishida N; Higuchi T; Miyazu T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
Sci Rep; 2021 Jun; 11(1):12431. PubMed ID: 34127687
[TBL] [Abstract][Full Text] [Related]
27. Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis.
Ierardi E; Giorgio F; Zotti M; Rosania R; Principi M; Marangi S; Della Valle N; De Francesco V; Di Leo A; Ingrosso M; Panella C
J Clin Pathol; 2011 Nov; 64(11):968-72. PubMed ID: 21945924
[TBL] [Abstract][Full Text] [Related]
28. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
[TBL] [Abstract][Full Text] [Related]
29. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.
Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S
J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.
Bessissow T; Lemmens B; Ferrante M; Bisschops R; Van Steen K; Geboes K; Van Assche G; Vermeire S; Rutgeerts P; De Hertogh G
Am J Gastroenterol; 2012 Nov; 107(11):1684-92. PubMed ID: 23147523
[TBL] [Abstract][Full Text] [Related]
31. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
[TBL] [Abstract][Full Text] [Related]
32. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.
Lobatón T; Bessissow T; De Hertogh G; Lemmens B; Maedler C; Van Assche G; Vermeire S; Bisschops R; Rutgeerts P; Bitton A; Afif W; Marcus V; Ferrante M
J Crohns Colitis; 2015 Oct; 9(10):846-52. PubMed ID: 26116558
[TBL] [Abstract][Full Text] [Related]
33. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.
Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Mertz Nielsen A
J Crohns Colitis; 2015 Aug; 9(8):625-32. PubMed ID: 25956537
[TBL] [Abstract][Full Text] [Related]
35. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.
Farkas K; Rutka M; Golovics PA; Végh Z; Lovász BD; Nyári T; Gecse KB; Kolar M; Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Malickova K; Bálint A; Nagy F; Bor R; Milassin Á; Szepes Z; Palatka K; Lakatos PL; Lukas M; Molnár T
J Crohns Colitis; 2016 Nov; 10(11):1273-1278. PubMed ID: 27106537
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
[TBL] [Abstract][Full Text] [Related]
38. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
[TBL] [Abstract][Full Text] [Related]
39. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
Sandborn WJ; Hanauer S; Lichtenstein GR; Safdi M; Edeline M; Scott Harris M
Aliment Pharmacol Ther; 2011 Oct; 34(7):747-56. PubMed ID: 21848857
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic and histological patchiness in treated ulcerative colitis.
Kim B; Barnett JL; Kleer CG; Appelman HD
Am J Gastroenterol; 1999 Nov; 94(11):3258-62. PubMed ID: 10566726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
